Comparative estimates of crude and effective coverage of measles immunization in low-resource settings: Findings from Salud Mesoamérica 2015

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Colson, K Ellicott ^a   Zúñiga Brenes, Paola ^c   Ríos Zertuche, Diego ^c   Conde Glez, Carlos J ^d   Gagnier, Marielle C ^b   Palmisano, Erin ^b   Ranganathan, Dharani ^e   Usmanova, Gulnoza ^b   Salvatierra, Benito ^f   Nazar, Austreberta ^f   Tristao, Ignez ^c   Sanchez Monin, Emmanuelle ^c   Anderson, Brent W ^g   Haakenstad, Annie ^b   Murphy, Tasha ^b   Lim, Stephen ^b   Hernandez, Bernardo ^b   Lozano, Rafael ^b,d   Iriarte, Emma ^c   Mokdad, Ali H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Salud Mesoamérica 2015 Inter American Development Bank   (Panama)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e GEORGE WASHINGTON UNIVERSITY   (United States)

^f DEPARTAMENTO DE CONSERVACIÓN DE LA BIODIVERSIDAD   (Mexico)

^g Napa County Health and Human Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE; VIRUS ANTIBODY;

ARTICLE; CHILD; CHILD HEALTH; CONTROLLED STUDY; DECISION MAKING; DRIED BLOOD SPOT TESTING; FEMALE; HEALTH CARE ACCESS; HEALTH CARE FACILITY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; MEXICO; NICARAGUA; PRESCHOOL CHILD; PUBLIC HEALTH; SEROLOGY; SEROPREVALENCE; URBAN AREA; ADOLESCENT; ADULT; BLOOD; DEVELOPING COUNTRY; DEVICES; DRUG STABILITY; DRUG STORAGE; ECONOMICS; HEALTH CARE SURVEY; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MEASLES VIRUS; MEDICAL RECORD; MIDDLE AGED; PREVENTIVE HEALTH SERVICE; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; UTILIZATION; VACCINATION; VIROLOGY;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DRIED BLOOD SPOT TESTING; DRUG STABILITY; DRUG STORAGE; FEMALE; HEALTH CARE SURVEYS; HEALTH RECORDS, PERSONAL; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; MEXICO; MIDDLE AGED; NICARAGUA; VACCINATION;

EID: 84940991004     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130697     Document Type: Article

References (34)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-128. doi: 10.1016/S0140-6736(12)61728-0 PMID: 23245604
2. Santos JI, Nakamura MA, Godoy MV, Kuri P, Lucas CA, Conyer RT. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned. J Infect Dis 2004; 189 Suppl 1: S243-250. PMID: 15106118
3. Lim SS, Stein DB, Charrow A, Murray CJ. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lancet 2008; 372(9655): 2031-46. doi: 10.1016/S0140-6736(08)61869-3 PMID: 19070738
4. Luman ET, Ryman TK, Sablan M. Estimating vaccination coverage: Validity of household-retained vaccination cards and parental recall. Vaccine 2009; 27(19): 2534-9. doi: 10.1016/j.vaccine.2008.10.002 PMID: 18948158
5. Hayford KT, Shomik MS, Al-Emran HM, Moss WJ, Bishai D, Levine OS. Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study. BMC Public Health 2013; 13: 1211. doi: 10.1186/1471-2458-13-1211 PMID: 24359402
6. National Institute of Public Health (Mexico). Mexico National Survey of Health and Nutrition 2011-2012; 2012. Cuernavaca, Mexico: National Institute of Public Health (Mexico).
7. National Institute for Public Health (Mexico). Mexico National Survey of Health and Nutrition 2005-2006; 2006. Cuernavaca, Mexico: National Institute for Public Health (Mexico).
8. National Institute of Statistics and Censuses (Nicaragua), Ministry of Health (Nicaragua), Macro International, Inc. Nicaragua Demographic and Health Survey 2001; 2001. Calverton, United States: Macro International, Inc.
9. Division of Reproductive Health-Centers for Disease Control and Prevention (CDC), National Institute for Development Information (Nicaragua). Nicaragua Reproductive Health Survey 2006-2007; 2007. Managua, Nicaragua: National Institute for Development Information (Nicaragua).
10. Ministry of Health (Nicaragua), National Institute for Development Information (Nicaragua). Nicaragua National Demographic and Health Survey 2011-2012; 2012. Managua, Nicaragua: National Institute for Development Information (Nicaragua).
11. Ministry of Health (Nicaragua), National Institute for Development Information (Nicaragua). Living Standards Measurement Survey 2005; 2005. Managua, Nicaragua: National Institute for Development Information (Nicaragua).
12. Miles M, Ryman TK, Dietz V, Zell E, Luman ET. Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature. Vaccine 2013; 31(12): 1560-8. doi: 10.1016/j.vaccine.2012.10.089 PMID: 23196207
13. Cutts FT, Izurieta HS, Rhoda DA. Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys. PLoS Med 2013; 10: e1001404. doi: 10.1371/journal.pmed.1001404 PMID: 23667334
14. Snijdewind IJM, van Kampen JJA, Fraaij PLA, van der Ende ME, Osterhaus AD, Gruters RA. Current and future applications of dried blood spots in viral disease management. Antiviral Res 2012; 93: 309-21. doi: 10.1016/j.antiviral.2011.12.011 PMID: 22244848
15. Pomelova VG, Osin NS. Prospects of the integration of dry blood spot technology with human health and environmental population studies. Vestn Ross Akad Meditsinskikh Nauk Ross Akad Meditsinskikh Nauk 2007; 10-6.
16. Parker SP, Cubitt WD. The use of the dried blood spot sample in epidemiological studies. J Clin Pathol 1999; 52: 633-9. PMID: 10655983
17. Spooner N. A glowing future for dried blood spot sampling. Bioanalysis 2010; 2: 1343-4. doi: 10.4155/bio.10.111 PMID: 21083330
18. McDade TW, Williams S, Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 2007; 44: 899-925. PMID: 18232218
19. National Research Council (US). Committee on Advances in Collecting and Utilizing Biological Indicators and Genetic Information in Social Science Surveys. Biosocial Surveys. Washington DC: National Academies Press (US); 2008.
20. SamoѤlovich EO, Svirichevskaia EI, Ermolaev MA. Comparative assessment of determination of measles virus IgG antibodies in blood serum and dried whole blood. Vopr Virusol 2008; 53: 46-8.
21. Novello F, Ridolfi B, Fiore L, Buttinelli G, Medda E, Favero A, et al. Comparison of capillary blood versus venous blood samples in the assessment of immunity to measles. J Virol Methods 1996; 61: 73-7. PMID: 8882939
22. Colson KE, Potter A, Conde-Glez C, Hernandez B, Ríos-Zertuche D, Zuňiga-Brenes, et al. Use of a commercial ELISA for the detection of measles-specific immunoglobulin G (IgG) in dried blood spots collected from children living in low-resource settings. J Med Virol 2015; in press.
23. World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system 2014 global summary: Measles reported cases. 2014. Available: http://apps.who.int/immunization-monitoring/globalsummary/timeseries/tsincidencemeasles.html. Accessed 29 May 2014.
24. World Health Organization (WHO). Reported measles cases and incidence rates by WHO Member States 2013, 2014 as of 05 May 2014. Available: http://www.who.int/immunization/monitoring-surveillance/burden/vpd/surveillance-type/active/measlesreportedcasesbycountry.pdf?ua=1. Accessed 29 May 2014.
25. Ruiz-Gómez J, Valdespino JL, Olaiz-Fernández G, Arias-Toledo E, Sepúlveda J. Encuesta serológica nacional del sarampión en niños: evidencias para su eliminación. Salud Pública México 2007; 49 suppl 3: S370-S376.
26. Gakidou E, Lozano R, González-Pier E, Abbott-Klafter J, Barofsky JT, Bryson-Cahn C, et al. Assessing the effect of the 2001-06 Mexican health reform: an interim report card. Lancet 2006; 368: 1920-35. PMID: 17126725
27. Mexican Ministry of Health. Effective coverage of the health system in Mexico 2000-2003; 2006. Federal District, Mexico: Mexican Ministry of Health.
28. Lozano R, Soliz P, Gakidou E, Abbott-Klafter J, Feehan DM, Vidal C, et al. Benchmarking of performance of Mexican states with effective coverage. Lancet 2006; 368: 1729-41. PMID: 17098091
29. Mokdad AH, Colson KE, Zúñiga-Brenes P, Ríos-Zertuche D, Palmisano EB, Alfaro-Porras E, et al. Salud Mesoamerica 2015 Initiative: design, implementation, and baseline findings. Popul Health Metr 2015; 13: 3. doi: 10.1186/s12963-015-0034-4 PMID: 25685074
30. Helfand RF, Kebede S, Gary HE, Beyene H, Bellini WJ. Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination. Clin Diagn Lab Immunol 1999; 6: 178-80. PMID: 10066650
31. WHO Department of Immunization, Vaccines and Biologicals. The Immunological Basis for Immunization Series: module 7: measles- Update 2009. 2009. Geneva, Switzerland: World Health Organization. Available: http://whqlibdoc.who.int/publications/2009/9789241597555-eng.pdf. Accessed 10 June 2014.
32. Collaborative Study by the Ministries of Health of Brazil, Chile, Costa Rica, Ecuador, and the Pan American Health Organization. Seroconversion rates and measles antibody titers induced by measles vaccine in Latin American Children 6-12 Months of Age. Bull Pan Am Health Organ 1982: 16.
33. Waibale P, Bowlin SJ, Mortimer EA, Whalen C. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda. Int J Epidemiol 1999; 28: 341-6. PMID: 10342701
34. de Quadros CA, Izurieta H, Caarrasco P, Brana M, Tambini G. Progress toward measles eradication in the region of the Americas. J Infect Dis 2003; 187: S102-S110. PMID: 12721900